在老鼠大脑中的阿片类结合部位对4,5-epoxymorphinansans具有高度选择性
概括
研究人员在老鼠大脑中发现了一个新的兰巴达位点,与已知的阿片类受体不同. 该网站显示某些阿片类化合物具有独特的结合特性,这表明药理学研究的新目标.
科学领域:
- 神经药理学神经药理学
- 受体结合研究研究.
背景情况:
- 已知多种类型的阿片类受体.
- 片受体对疼痛调节和成至关重要.
研究的目的:
- 为了描述大鼠大脑中一个新的结合部位,称为兰达部位.
- 与已建立的阿片类受体相比,研究兰巴部位的独特特性.
主要方法:
- 在实验室结合测试中使用老鼠大脑同质化物.
- 使用像纳洛和吗啡这样的4,5-epoxymorphinans进行选择性连接键结合研究.
主要成果:
- 兰巴部位对4,5-epoxymorphinans具有选择性.
- 在体内和体外观察到对纳洛的高度亲和力,但在体外迅速下降.
- 兰巴网站的区域分布与经典的阿片类受体有很大的不同.
结论:
- 兰巴部位代表了一个独特的阿片类受体亚型,具有独特的药理特征.
- 它在体外快速转化表明了复杂的调节机制.
- 独特的分布意味着在中枢神经系统中具有特殊的作用.
相关概念视频
Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Drug-Receptor Interaction: Antagonist
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...


